tirzepatide cvot results Comparison of and dulaglutide on major adverse cardiovascular events in participants with type 2 diabetes and atherosclerotic cardiovascular disease: SURPASS‐CVOT design and baseline characteristics SURPASS-CVOT — Leicester Diabetes Centre

Metabolic abnormalities directly drive vascular remodeling through energy metabolic reprogramming, substrate competition, and signaling pathway activation, while the process of vascular remodeling further exacerbates metabolic imbalance, forming a pathological cascade reaction

Recent trends in globalization of industry R&D clinical trials: are emerging markets losing their allure?, Applied Clinical Research Clinical Trials and Regulatory Affairs 2017;4:175-182

Because it reduces hunger and increases satiety, patients often find it easier to make healthy choices and avoid emotional eating

10.1186/s12915-021-01168-0 100 XuK.GuoJ.GeM.YinJ.ZhangH.YinJ.et al